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OBJECTIVE—Physical activity reduces high-sensitivity C-reactive protein (hs-CRP), cardio-
vascular disease (CVD), and total mortality in type 2 diabetic patients. However, it is not known
whether the effects of physical activity on mortality depend on the levels of hs-CRP in patients
with type 2 diabetes.
RESEARCH DESIGN AND METHODS—We prospectively followed-up on 569 type 2
diabeticpatients,aged45–64years,whowerefreeofCVDatbaseline.Participantswerestratiﬁed
according to the level of hs-CRP (,1.0, 1.0–3.0, or .3.0 mg/L) and the degree of physical
activity (0–4 metabolic equivalent tasks [METs] or .4 METs). The Cox proportional hazards
modelwasused to estimate thejoint associationbetweenphysical activityand hs-CRPlevelsand
the risk of mortality.
RESULTS—Duringan18-yearfollow-up,356patientsdied,217ofwhomdiedofCVD.Those
whowerephysicallymoreactivehadsigniﬁcantlyreducedtotal,CVDandcoronaryheartdisease
(CHD) mortality among patients with elevated hs-CRP levels (.3m g / L ) .T h e s eﬁndings
persistedinmultivariable analyses. However,inpatients with anhs-CRP level,1 mg/L or between
1 and 3 mg/L, there was no statistically signiﬁcant relationship between physical activity and CVD
or CHD mortality.
CONCLUSIONS—Physicalactivityreducestotal,CVD,andCHDmortalityintype2diabetic
patients with elevated hs-CRP levels. This suggests that the anti-inﬂammatory effect of physical
activity may counteract increased CVD and CHD morbidity and mortality associated with high
CRP levels.
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A
role for inﬂammation has become
well established in the pathogenesis
of atherosclerosis (1). Several cyto-
kines and acute-phase reactants have
been examined as predictors of athero-
sclerotic disease, but the best studied
is high-sensitivity C-reactive protein
(hs-CRP). hs-CRP also has been shown
to predict,independently of conventional
riskfactors,coronaryheartdisease(CHD)
andcardiovasculardisease(CVD)mortal-
ity in the general population and also in
patients with type 2 diabetes (2,3). Fur-
thermore, CHD mortality risk is from
two- to fourfold in patients with type 2
diabetes in comparison with nondiabetic
subjects, and .50% of patients with type 2
diabetesdiefromCHD(4).Therefore,ithas
been contemplated that anti-inﬂammatory
therapies might reduce excess mortality in
type 2 diabetic patients.
Physical activity is known to reduce
inﬂammation and hs-CRP levels (5,6).
However, no study has investigated the
anti-inﬂammatory effect of physical activ-
ity on CVD mortality. Therefore, we in-
vestigated the association of physical
activity with CVD and total mortality
among patients with type 2 diabetes
with and without elevated levels of
hs-CRP in a large, population–based,
18-year follow-up study.
RESEARCH DESIGN AND
METHODS—A more detailed descrip-
tion of the study subjects has been dis-
cussed elsewhere (7). In brief, a total of
1,059 type 2 diabetic patients (581 men
and 478 women), aged 45–64 years, who
were living in the Turku University Cen-
tral Hospital district in West Finland or
in the Kuopio University Hospital district
in East Finland, were identiﬁed on the
basis of a national drug reimbursement
register. Patients with type 1 diabetes
were excluded on the basis of early-onset
diabetes, history of ketoacidosis, and
glucagon-stimulated C-peptide measure-
ment at baseline.
We excluded from statistical analyses
a total of 452 subjects who had angina
pectoris, possible or deﬁnite stroke, pos-
sible or deﬁnite myocardial infarction
(MI), intermittent claudication or ampu-
tationatthebaselineexamination,and30
subjects who died or had a severe CVD
event (MI, stroke, or lower-limb amputa-
tion)duringthe ﬁrst2yearsofthefollow-
up based on the assumption that the
subjects with positive exclusion criteria
verylikelyhadchangedtheirexercisehabits
as a result of severe disease at baseline. We
additionally excluded eight patients be-
cause of missing hs-CRP data. Thus, the
ﬁnal study population consisted of 569
type 2 diabetic patients (308 men and 261
women).
Baseline study
The baseline examination in 1982–1984
included an interview on the history of
smoking,alcoholintake,physicalactivity,
use of medication, and history of chest
pain suggestive of CHD. The methods
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ously (7).
Specially trained nurses recorded
chest-pain symptoms suggestive of an-
gina pectoris, MI, and intermittent clau-
dication using the Rose cardiovascular
questionnaire (8). Medical records of pa-
tients who reported that they had been
admitted to the hospital for chest pain
were reviewed by two investigators
(M.L. and T.R.) after a careful standardi-
zation of the methodology. The World
Health Organization criteria for veriﬁed
deﬁnite or possible MI based on the
symptoms of chest pain, electrocardio-
gram changes, and enzyme determina-
tions were used to deﬁne previous MI
(9). Electrocardiogram abnormalities
were classiﬁed according to the Minne-
sotacode(8).WorldHealthOrganization
criteria were used to deﬁn eap r e v i o u s
deﬁnite or possible stroke (10). The
Rosequestionnairewas usedtodeﬁnein-
termittent claudication (8). Nontrau-
matic lower-extremity amputations were
recorded. Blood pressure was measured
with the subject in the sitting position
aftera5-minrest,andBMIwascalculated
as weight in kilograms divided by the
square of height in meters. Hypertension
was deﬁned as systolic blood pressure
$160 mmHg, diastolic pressure $95
mmHg, or antihypertensive drug treat-
ment.
Biochemical methods
Aftera12-hfast,allbloodspecimenswere
taken at 0800 h. Glycosylated hemoglo-
bin A1 (HbA1) (reference range in non-
diabetic subjects 5.5–8.5%) levels were
determined by afﬁnity chromatography
(Isolab, Akron, OH). Serum total choles-
terol, HDL cholesterol, and triglycerides
were determined with standard labora-
torymethods(7).TheCoomassieBrilliant
Blue method was used to measure total
urinary protein concentrations from
a morning spot-urine specimen (11).
hs-CRP was analyzed from baseline sam-
ples with a latex turbidimetric immuno-
assay (Wako Chemicals, Neuss, Germany).
The analytical detection limit for this
method is 0.06 mg/L. The interassay coefﬁ-
cient of variation was 3.3 and 2.7% at mean
hs-CRP levels of 1.52 (n = 116) and 2.51
(n = 168) mg/L, respectively.
Assessment of physical activity
Metabolic equivalent task (MET) was
used to assess the physical activity of
subjects. One MET is deﬁned as the
energy expenditure for sitting quietly. It
isequivalentto3.5mLoxygenuptakeper
kilogram of body weight per minute. For
example, four METs require four times
the subject’s metabolic energy expendi-
ture of sitting quietly, and it is equivalent
to brisk walking.
At the baseline examination, occu-
pational, commuting, and leisure-time
physical activities were assessed using a
self-administered questionnaire. After the
interview,acorrespondingMETvaluewas
assigned for each of the three categories,
according to the intensity of the activity
(12). Occupational activities were divided
into seven classes as follows: 1) no work
(1.5 METs); 2)s i t t i n go f ﬁce work (1.75
METs) (e.g., car driving or secretarial);
3) other sitting work (2.5 METs) (e.g.,
salesman or repair person); 4) light mov-
ing work (3.5 METs) (e.g., store assistant
oractiveofﬁcework);5)moderatemoving
work (5 METs) (e.g., light industrial
work); 6) active work (7.25 METs) (e.g.,
heavy industrial work or farm work); and
7) very heavy manual work (10 METs)
(e.g., woodcutter, lifting .40 kg). The
daily commuting journey was categorized
into three classes for summer and winter
separately as follows: 1) using motorized
transportation (1.5 METs); 2) bicycling
(5 METs); and 3) walking (3.5 METs).
Leisure-time physical activity was classi-
ﬁed, for summer and winter separately,
as follows: 1) little exercise (2 METs) (e.g.,
reading); 2) irregular exercise (3 METs)
(e.g.,ﬁshingandwalkingthedog);and3)
regular exercise (2.5–12.5 METs), where
subjects stated their regular sport activi-
ties and whether it involved sweating
and/or breathlessness (e.g., swimming
or skiing). In all statistical analyses, sum-
merandwinterlevelswerecombinedand
the calculated mean was used. The ques-
tionnaire on physical activity used in this
study has been validated on 1,400 sub-
jects. The reliability, estimated by k coef-
ﬁcients, was at least 0.6 (12). The same
questionnaire also was used in our pre-
vious study (13).
Therewasawidevariationinphysical
activity class (occupational, commuting,
and leisure-time physical activities) with
the highest MET. Therefore, we decided
to use the highest intensity of occupa-
tional, commuting, or leisure-time activ-
ities to represent the overall activity level
of the subjects.
Follow-up study
The 18-year follow-up period lasted until
1 January 2001. Information on the vital
status of the participants and copies of
death certiﬁcates of all deceased subjects
who had diedbefore1 January 2001 were
obtainedfromtheCauseofDeathRegister
(Statistics Finland). All death certiﬁcates
of participants were reviewed by two of
the authors (A.J. and S.L.). In the ﬁnal
classiﬁcation of causes of death, hospital
records and autopsy records also were
used, if available.
The end points used in this study
were total mortality, CHD mortality (i.e.,
ischemic heart disease and myocardial
infarction [ICD-9 codes 410–414]), and
CVD mortality (i.e., diseases of the circu-
latory system, CHD, and cerebrovascular
diseases contributing the vast majority of
the cases [ICD-9 codes 390–459]).
The ethics committees of Turku Uni-
versity and Turku University Central
Hospital and the University of Kuopio
approved the study. Informed written
consent was obtained from all partici-
pants.
Statistical analyses
All statistical analyses were performed
using SPSS for Windows (version 15.0;
SPSS, Chicago, IL). Data for continuous
variables are expressed as means 6 SD
and categorical variables as percentages.
Student t tests for independent samples
were used to assess differences between
the groups. Because of their skewed dis-
tribution, triglycerides and urinary pro-
tein were analyzed after logarithmic
transformation. The x
2 test was used to
compare categorical variables. The Cox
proportional hazards model was used to
estimate the joint association of physical
activity level and hs-CRP categories with
the risk of mortality. Participants were
classiﬁed according to physical activity
(0–4M E T sa n d.4 METs) and hs-CRP
level (,1.0, 1.0–3.0, or .3.0 mg/L).
hs-CRP cut points are based on the rec-
ommendations of American Heart As-
sociation for low risk (,1.0 mg/L),
intermediate risk (1.0–3.0 mg/L), and
high risk (.3.0 mg/L) (14). Unadjusted
and adjusted hazard ratios and their
95% CIs were calculated. Adjustment
was performed for age, sex, duration of
diabetes, area of residence (East or West
Finland), total cholesterol, use of alcohol
(nonusers or users), smoking (nonsmoker
orsmoker), hypertension (no or yes = sys-
tolic blood pressure $160 mmHg, dia-
stolic pressure $95 mmHg, or drug
treatment), HDL cholesterol, triglycerides
(log), HbA1, diabetes medication (diet
only, oral drugs, or insulin), urinary pro-
tein (log), and BMI. The Kaplan-Meier
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tions between different levels of physical
activity and hs-CRP with CVD and CHD
mortality. In the Kaplan-Meier analysis,
we combined low and average hs-CRP
groups because they did not differ in
CVDorCHDmortalityinrelationtophys-
icalactivity.Becauseofthesimilarityofthe
prognosisbetweenCHDandCVDmortal-
ity, only the Kaplan-Meier curve for CVD
mortality is shown. Men and women were
combinedinallstatisticalanalysesbecause
there were no interactions between sex
and physical activity or sex and hs-CRP.
P value ,0.05 was considered to be sta-
tistically signiﬁcant.
RESULTS—Thegeneralcharacteristics
of the study population at baseline,
according to physical activity, are pre-
sented in Table 1. Physically active type
2d i a b e t i cp a t i e n t sw e r es l i g h t l yy o u n -
ger; had lower triglyceride levels, BMI,
and blood pressure; smoked less often;
receivedinsulintherapymoreoften;and
had lower hs-CRP levels than physically
inactive patients. Physically active patients
also tended to have lower total cholesterol.
A total of 8.8% of the subjects were physi-
cally active and had hs-CRP levels .3.0
mg/L, 15.6% were physically active and
had hs-CRP levels between 1.0 and 3.0
mg/L, and 15.1% were physically active
andhadhs-CRPlevels,1.0mg/L.Thecor-
responding percentages among physically
inactive patients were 18.6, 21.1, and
20.7%, respectively.
Outcome according to physical
activity and hs-CRP
Of physically active patients with high
hs-CRP levels, a total of 30 (60.0%) died,
21 (42.0%) of whom died from CVD.
Of subjects with intermediate hs-CRP
levels, a total of 50 (56.2%) died, 33
(37.1%) of whom died from CVD. Of the
subjects with low hs-CRP levels, a total of
37 (43.0%) died, 19 (22.1%) of whom
died from CVD. Of physically inactive
subjects withhighhs-CRP levels,atotal of
85 (80.2%) died, 57 (53.8%) of whom
died from CVD. Of subjects with inter-
mediate hs-CRP levels, a total of 80
(66.7%) died, 45 (37.5%) of whom died
from CVD. Of subjects with low hs-CRP
levels, a total of 67 (56.8%) died, 39
(33.1%) of whom died of CVD.
In univariate or multivariate analyses
among subjects with hs-CRP levels #3.0
mg/L, there were no signiﬁcant differ-
ences in any of the outcome variables
betweenphysicallyactiveandinactivepa-
tients. However, in both univariate and
multivariate analyses among patients
with hs-CRP levels .3.0 mg/L, the group
that was more physically active had a sig-
niﬁcantly reduced relative risk for total
mortality, CVD mortality, and CHD mor-
tality (Table 2).
The Kaplan-Meier curve (Fig. 1) in-
dicates the cumulative survival for
physically active and inactive patients
stratiﬁed by baseline hs-CRP level (low-
intermediate versus high-level patients).
Those patients with hs-CRP levels .3.0
mg/Latbaselineandwhowerephysically
inactive had a poorer prognosis than
those who were physically active. This
became evident after 4 years of follow-
up. Physically active patients with high
hs-CRP had a similar prognosis with re-
spect to CVD mortality compared with
physically inactive patients with low or
intermediate hs-CRP levels.
CONCLUSIONS—As far as we know,
there are no previous studies that aimed
to investigate the preventive effect of
physical activity on CVD mortality in
diabetic subjects with varying CRP levels.
In our prospective study of middle-aged
Finnish type 2 diabetic patients, physical
activity was signiﬁcantly associated with
reduced total, CVD, and CHD mortality
rates among patients with elevated hs-CRP
levels. These associations were indepen-
dent of conventional CVD risk factors,
urinary protein, duration of diabetes, di-
abetes treatment, and glycemic control. In
patients with hs-CRP levels #3m g / L ,a
beneﬁcial effect of physical activity was
not observed. These ﬁndings are in agree-
ment with the hypothesis that physical
activity may counteract, at least to some
extent, the adverse effects of chronic in-
ﬂammation on the cardiovascular system
and thus reduce CVD mortality. However,
it must be noted that in our study, patients
with type 2 diabetes at baseline, regardless
of physical activity, had unsatisfactorily
controlled diabetes, and, therefore, our
study results and conclusions are within
the context of such patients.
The pathophysiological basis for the
associationof CRP with CVDstillremains
unclear. hs-CRP may be a marker of
Table 1—Baseline characteristics and the number of subjects with various outcomes
according to physical activity level among type 2 diabetic patients
Physical activity
P 0–4M E T s .4 METs
n 347 230
Age (years) 58.2 6 5.1 56.5 6 5.3 , 0.001
Duration of diabetes (years) 7.9 6 4.0 7.8 6 4.0 0.689
Total cholesterol (mmol/L) 6.62 6 1.68 6.39 6 1.38 0.089
HDL cholesterol (mmol/L) 1.24 6 0.35 1.28 6 0.36 0.195
Triglycerides (mmol/L) 2.39 6 2.58 1.89 6 1.24 0.006
HbA1 (%) 9.7 6 1.8 9.9 6 3.0 0.222
BMI (kg/m
2) 29.9 6 5.9 28.2 6 4.4 ,0.001
Urinary protein (mg/L) 207.4 6 249.7 173.1 6 272.7 0.121
Women (%) 50.1 38.7 0.007
Current smokers (%) 19.6 11.3 0.008
Hypertension medication (%) 61.7 52.2 0.024
Alcohol users (%) 37.5 42.6 0.216
Diabetes treatment (%) 0.054
Diet only 13.0 16.1
Oral drugs 76.9 68.3
Insulin therapy 10.1 15.7
hs-CRP (n)0 . 0 8 0
,1m g / L 1 1 8 8 6
1–3 mg/L 120 89
.3m g / L 1 0 6 5 0
hs-CRP (mg/L) 3.1 6 3.8 2.4 6 3.7 0.044
Subjects with end points (n)
Total mortality 234 122
CVD mortality 143 74
CHD mortality 98 51
Data are means 6 SD, unless otherwise indicated.
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factor for CVD (15). CRP, known to be
produced primarily by the liver in re-
sponse to inﬂammatory cytokines (e.g.,
interleukin [IL]-6), also is produced by
adipocytes from adipose tissue and ath-
erosclerotic plaques (16,17). It is involved
inatherogenesisbypromotingendothelial
cell activation, macrophage recruitment,
and foam cell generation within the arte-
rialwall(18).CRP predicts CVD mortality
not only in type 2 diabetic patients but
also in the general population (2,3). In-
ﬂammation also has been associated with
insulin resistance syndrome and the path-
ogenesis of type 2 diabetes (19).
Evidence of an independent, inverse,
dose-response relationship between
physical activity levels and systemic CRP
concentration has been provided by sev-
eral studies (5,6). This is in accordance
with our study, in which physically active
subjects at baseline had signiﬁcantly
lower hs-CRP levels than physically inac-
tive subjects. Furthermore, in our study,
physically active subjects with high hs-CRP
levels had reduced total, CVD, and CHD
mortality rates.
The molecular mechanism of how
physical activity reduces inﬂammation and
suppresses CRP levels is not well deﬁned.
After short-term strenuous exercise, there
is a transient increase in serum CRP,
mediatedbythecytokinesystem,mainly
by IL-6 (20–22). However, acute exercise
also produces various anti-inﬂammatory
mediators, including IL-10, thus leading
primarily to an anti-inﬂammatory effect.
Chronic physical activity seems to reduce
CRP levels by several mechanisms, in-
cluding a decrease in cytokine produc-
tion (e.g., IL-1b, IL-6, tumor necrosis
factor-a, interferon-g, and leptin) by adi-
pose tissue, skeletal muscle, endothelial
cells, and blood mononuclear cells. Fur-
thermore, exercise induces an increase in
atheroprotective cytokines (e.g., IL-4 and
IL-10) and adiponectin and improves en-
dothelial function and insulin sensitivity
(23). The antioxidant effect of exercise
also may contribute to the reduction of
CRP levels and inﬂammation (5,23).
In our study, patients with low or
intermediate hs-CRP levels did not seem
to beneﬁt from physical activity as much
as patients with higher hs-CRP levels.
Physically active subjects with high
hs-CRP levels had almost similar CVD
mortality as those with intermediate or
lowhs-CRPconcentrationsandlowphys-
icalactivity.Itcanbespeculatedthatphys-
ically active patients with hs-CRP levels
.3 mg/L would have had much higher
hs-CRP concentrations if they had been
sedentary. This is in accordance with the
Heritage Family Study, a large, exercise
study in which plasma CRP levels were
signiﬁcantly reduced with 20 weeks of
aerobic training only in the subgroup
of subjects with a baseline CRP level
.3.0 mg/L (24). It also is possible that
the improvement in mortality associated
withphysicallyactivepatientswithhigher
hs-CRP levels could have been attributed
to the previous state of atherosclerosis in
the arteries as well as to the effect on the
atherogenetic process after the baseline
examination.
Table 2—Hazard ratios (physically active versus inactive) for total, CVD, and CHD
mortality stratiﬁed by hs-CRP
Variables
Hazard ratio (95% CI)
Age-adjusted relative risk Multivariate-adjustedrelativerisk
Active versus inactive P Active versus inactive P
Total mortality
hs-CRP ,1.0 mg/L 0.79 (0.53–1.19) 0.266 0.96 (0.57–1.59) 0.863
hs-CRP 1.0–3.0 mg/L 0.82 (0.57–1.17) 0.263 1.10 (0.71–1.70) 0.667
hs-CRP .3.0 mg/L 0.51 (0.33–0.77) 0.001 0.51 (0.30–0.85) 0.011
CVD mortality
hs-CRP ,1.0 mg/L 0.68 (0.39–1.18) 0.167 0.74 (0.36–1.51) 0.408
hs-CRP 1.0–3.0 mg/L 0.97 (0.61–1.53) 0.889 1.59 (0.89–2.84) 0.119
hs-CRP .3.0 mg/L 0.55 (0.33–0.92) 0.022 0.53 (0.28–0.99) 0.045
CHD mortality
hs-CRP ,1.0 mg/L 0.63 (0.33–1.21) 0.163 0.70 (0.30–1.63) 0.405
hs-CRP 1.0–3.0 mg/L 1.09 (0.63–1.87) 0.765 1.61 (0.82–3.17) 0.166
hs-CRP .3.0 mg/L 0.49 (0.26–0.92) 0.027 0.36 (0.15–0.84) 0.019
Variables in multivariable adjustment: age, sex, area of residence, diabetes duration, total cholesterol, HDL
cholesterol, triglycerides (log), proteinuria (log), smoking, alcohol, HbA1, presence of hypertension, BMI,
and type of diabetes therapy.
Figure 1—Kaplan-Meier survivalcurve for CVDmortality amongphysicallyactive and inactive
type2diabeticpatientsstratiﬁedbybaselinehs-CRPlevels.METrepresentsthephysicalactivityofthe
subjects. ○, physically inactive patients (0–4 METs) with hs-CRP levels #3.0 mg/L; ●,p h y s i c a l l y
inactive patients (0–4 METs) with hs-CRP levels .3.0 mg/L; □, physically active patients (.4
METs) with hs-CRP levels #3.0 mg/L; ■, physically active patients (.4 METs) with hs-CRP levels
.3.0 mg/L. P value denotes the difference between the survival curves (log rank).
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our baseline study was carried out in
1982–1984, and practically none of the
participants were on lipid-lowering med-
ications. Statin treatment did not become
common until the latter half of 1990s,
and, therefore, it is unlikely that lipid-
lowering therapy, which is known to de-
crease hs-CRP levels (25), caused a major
bias in our study. Second, unlike many
other similar studies, we had data on glu-
cosecontrol,diabetesduration,andmode
of diabetestreatment. Third, we excluded
patients with type 1 diabetes by perform-
ing the postglucagon C-peptide measure-
ment. Finally, to avoid a potential bias
from the possibly increased early mortal-
ity attributed to a severe disease at base-
line in patients with low physical activity,
weexcludedallsubjectswithpreviousdi-
agnoses of angina pectoris, possible or
deﬁnitestroke,possibleordeﬁniteMI,in-
termittent claudication, or amputation at
baseline and those who died or received a
severe disability during the ﬁrst 2 years of
follow-up.
Our study also has some limitations.
We had only one baseline hs-CRP de-
termination and no follow-up values.
Furthermore, we evaluated physical ac-
tivity only at baseline, and we have no
data on changes in physical activity dur-
ing the follow-up. However, we used the
highest MET value of physical activity at
work or during leisure-time or commut-
ingtorepresentoverallphysicalactivityto
minimize this limitation. As a result of
theserestrictions,itislikelythatourstudy
underestimates rather than overestimates
the association of physical activity and
elevated hs-CRP levels with cardiovascu-
lar outcomes and total mortality.
In conclusion, physical activity re-
duced cardiovascular and total mortality
in middle-aged type 2 diabetic subjects
with elevated hs-CRP levels .3.0 mg/L,
whereas this beneﬁcial effect was not ob-
served in patients with hs-CRP levels
#3.0 mg/L, suggesting that the decrease
in CVD mortality in physically active pa-
tientsmayreﬂectananti-inﬂammatoryef-
fect of exercise independent of traditional
CVD risk factors. These observations may
have clinical implications when advising
physical activity as therapy for type 2 di-
abetic patients.
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